RPFGX | RYKIX | RPFGX / RYKIX | |
Total Expense Ratio | 0.95 | 1.39 | 68% |
Annual Report Gross Expense Ratio | 0.95 | 1.43 | 66% |
Fund Existence | 34 years | 27 years | - |
Gain YTD | -9.099 | -15.730 | 58% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 890M | 22.1M | 4,027% |
Annual Yield % from dividends | 1.48 | 3.38 | 44% |
Returns for 1 year | 5.27 | 1.00 | 528% |
Returns for 3 years | 13.97 | -3.71 | -376% |
Returns for 5 years | 75.00 | 63.11 | 119% |
Returns for 10 years | 59.16 | 54.12 | 109% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 74.88 | 5.08 | +7.28% |
SPDR® S&P Biotech ETF | |||
MAYT | 32.04 | 2.10 | +7.01% |
AllianzIM U.S. Large Cp Buffer10 May ETF | |||
FLV | 65.46 | 3.13 | +5.02% |
American Century Foc Lrg Cp Val ETF | |||
MARW | 30.57 | 1.29 | +4.39% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
IBTJ | 21.68 | -0.11 | -0.49% |
iShares iBonds Dec 2029 Term Tr ETF |